Welcome, Guest
Username: Password: Remember me
General
  • Page:
  • 1

TOPIC: Management option correction

Management option correction 17 Mar 2017 19:33 #9026

  • myownhedgefund
  • myownhedgefund's Avatar Topic Author
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 2820
  • Thank you received: 201
Well it seems there was a mistake and management options have been slightly reduced.
Hedrick now 96,350 The rest get 31,100

Here is the one for Hedrick:
secfilings.nasdaq.com/filingFrameset.asp?FilingID=11940613&RcvdDate=3/17/2017&CoName=CYTORI%20THERAPEUTICS%2C%20INC.&FormType=4/A&View=html

Please Log in or Create an account to join the conversation.

Management option correction 18 Mar 2017 05:33 #9027

  • rodney.strongg
  • rodney.strongg's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1329
  • Thank you received: 19

myownhedgefund wrote: Well it seems there was a mistake and management options have been slightly reduced.
Hedrick now 96,350 The rest get 31,100

Here is the one for Hedrick:
secfilings.nasdaq.com/filingFrameset.asp?FilingID=11940613&RcvdDate=3/17/2017&CoName=CYTORI%20THERAPEUTICS%2C%20INC.&FormType=4/A&View=html



Obviously, the option change was no mistake - either the institutional investors prevailed that the first grant was too obscene, and/or more likely, the first grant was premised on completing a partnership before the CC and that has not been accomplished.

Please Log in or Create an account to join the conversation.

Management option correction 18 Mar 2017 08:13 #9028

  • waddlingwillbologni
  • waddlingwillbologni's Avatar
  • Visitor
  • Visitor
Incentive based options are not based on prior performance, e.g., the earlier attainment of a partnership. This seems to be a major misconception on the board. Also, to think that a certain amount of options were granted based on closing a partnership within a week, and then shares were reduced because that partnership didn't happen in that week, is ludicrous.

Please Log in or Create an account to join the conversation.

Management option correction 18 Mar 2017 09:40 #9029

  • rodney.strongg
  • rodney.strongg's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1329
  • Thank you received: 19
SURE! LOL!

Please Log in or Create an account to join the conversation.

Management option correction 18 Mar 2017 13:03 #9030

  • myownhedgefund
  • myownhedgefund's Avatar Topic Author
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 2820
  • Thank you received: 201
Whatever the reason...the "mistake" didn't seem to be a simple typo.

Original awards were approx. 35% higher than the amended reward.

No amendment for the BOD though.

Please Log in or Create an account to join the conversation.

Management option correction 18 Mar 2017 13:51 #9031

  • waddlingwillbologni
  • waddlingwillbologni's Avatar
  • Visitor
  • Visitor
I highly doubt it was a coincidence that the filing of the reduction/amendment and the earnings date announcement were the same day. Like I suggested earlier, it seems to me that oversight was completed on their incompetence.

Please Log in or Create an account to join the conversation.

Management option correction 18 Mar 2017 14:33 #9032

  • myownhedgefund
  • myownhedgefund's Avatar Topic Author
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 2820
  • Thank you received: 201
wadd
Most of us have been aware for many years the quality we have in the stewardship of our investment.
With no revenues to speak of, no partnerships, and lacking volume to sell new shares into...where do the millions still needed come from ? Its the only question that really matters next week.

Please Log in or Create an account to join the conversation.

Management option correction 18 Mar 2017 16:00 #9033

  • waddlingwillbologni
  • waddlingwillbologni's Avatar
  • Visitor
  • Visitor
That I don't know. It's starting to look like the acquisition was a last ditch, incredibly high risk attempt to rally investor/partner enthusiasm -- it appears to be failing.

Please Log in or Create an account to join the conversation.

Management option correction 18 Mar 2017 16:45 #9034

  • myownhedgefund
  • myownhedgefund's Avatar Topic Author
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 2820
  • Thank you received: 201
Well if nothing else its (Azaya) a distraction from the failure of the MAP !
This summer sees the 1 yr anniversaries of Kesten dismissal and the release of the independent auditors KPMG. Let alone we have the 2 year data of our OA experiment....Hmmm...who says no partner appears...LOL No kidding on that dismal data that they still try to spin that if waiting 2 years to see a result a partner will come. Also late last summer the questions of the MAP began to show up. A summer of discontent indeed.
Who knows what they say next week...story time is always entertaining but hard on the pocketbook.

Please Log in or Create an account to join the conversation.

Management option correction 22 Mar 2017 11:55 #9042

  • waddlingwillbologni
  • waddlingwillbologni's Avatar
  • Visitor
  • Visitor
Azaya is not only a distraction from the failure of MAP but also a fallback if/when scleroderma fails, which, based on history, is a very high likelihood.
Regarding knee osteoarthritis: if anyone still considers any possibility of a Cytori success, I strongly suggest a reassessment of logic -- a more advanced regenerative medicine treatment for this disorder is already FDA approved.

Please Log in or Create an account to join the conversation.

Management option correction 22 Mar 2017 17:17 #9043

  • Wall Street Titan
  • Wall Street Titan's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 886
  • Thank you received: 148
Azaya can only be a fallback if they partner out the oncology drug SOON for at least $15MM up front. How many think Cytori will succeed here?

Please Log in or Create an account to join the conversation.

Management option correction 22 Mar 2017 18:28 #9044

  • waddlingwillbologni
  • waddlingwillbologni's Avatar
  • Visitor
  • Visitor
My thoughts exactly re. Azaya and the oncology partnership. Unfortunately, based on Cytori's track record and Azaya's failure to previously secure a partnership, it seems the answer is obvious as to whether Cytori will be successful. Some on this board seem to always be searching for some hidden, undisclosed reason to maintain hope when the facts are the facts and they are never favorable for Cytori. Granted, I'm a shareholder and am also in this embarrassing boat. The fact remains, however, that Cytori has no superstars on the business/finance side nor on the the science/medical side, and it's my belief that the rare success story in pharma and/or biotechs requires the pairing of superstar science/medical personnel with superstar finance/business people. We have neither. We have a CEO who is trying to walk a tight rope between being an amateur business man/entrepreneur and being an unimpressive biomedical scientist. He has no impressive credits on either side of the rope. It doesn't work. It results in failure after failure, lack of interest from partners, and a sinking stock price. As proven by the facts.

Please Log in or Create an account to join the conversation.

  • Page:
  • 1
Time to create page: 0.134 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites